|
STOCKHOLDERS' EQUITY - Schedule of Outstanding Warrants (Details) (USD $)
|
0 Months Ended | 1 Months Ended | 3 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|---|
|
Aug. 19, 2013
|
Jul. 29, 2013
|
Jul. 25, 2013
|
Jun. 30, 2013
|
Dec. 31, 2013
|
Dec. 31, 2013
Warrants
|
Dec. 31, 2013
Warrants
|
|
| Number Warrants | |||||||
| Warrants, beginning balance | 199,162 | ||||||
| Granted | 582,175 | ||||||
| Cancelled | |||||||
| Forfeited | (73,077) | ||||||
| Exercised | |||||||
| Warrants, ending balance | 708,260 | ||||||
| Weighted Average Exercise Price | |||||||
| Weighted average exercise price, beginning balance | 6.65 | ||||||
| Granted | $ 6.50 | ||||||
| Forfeited | $ 6.50 | ||||||
| Warrant Exercise Price | $ 6.66 | ||||||
| Vested and exercisable | $ 6.66 | ||||||
| Weighted Average Remaining Contractual Life | |||||||
| Weighted average contractual life, beginning balance | 6 years 6 months 7 days | ||||||
| Granted | 2 years 5 months 16 days | ||||||
| Forfeited | 8 years 0 months 29 days | ||||||
| Weighted average contractual life, ending balance | 2 years 9 months | ||||||
| Grant date fair value (per share) | $ 5.85 | $ 7.00 | $ 6.85 | $ 5.03 | $ 6.00 | $ 6.50 | |
| X | ||||||||||
|
- Definition
No authoritative reference available. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
|
- Definition
Weighted average remaining contractual term for equity-based awards excluding options forfeited in the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
|
- Definition
Weighted average remaining contractual term for equity-based awards excluding options granted in the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
|
- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of warrants. No definition available.
|
| X | ||||||||||
|
- Definition
Weighted average price at which grantees could have acquired the underlying shares with respect to stock warrants that were terminated. No definition available.
|
| X | ||||||||||
|
- Definition
The weighted average exercise price of warrants vested and exercisable. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of non-option equity instruments exercised by participants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Net number of non-option equity instruments granted to participants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|